-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Biomedical Engineering
- Cardiology
- Clinical Trials
- Clinics
- Consumer Products
- Counterfeit Products
- Critical Care Medicine
- Dentistry
- Dermatology
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA 2013
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Home Care
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Nephrology
- Neurology
- Nursing
- OBGYN
- Oncology
- Ophthalmology
- Orthopaedic Surgery
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Physical Medicine
- Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Risk Manager
- Surgery
- Uncategorized
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
Category Archives: FDA 2012
MedWatch December 2012 Safety Labeling Changes
The MedWatch December 2012 Safety Labeling Changes posting includes 42 products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE INSERT. The “Summary Page” provides a listing of drug names … Continue reading
Praxair Inc Grab n Go Vantage Portable Oxygen Cylinder Class I Recall
Praxair Inc., Grab ‘n Go Vantage Portable Oxygen Cylinder Units: Class I Recall – Risk of Fire Inside Cylinder Unit AUDIENCE: Risk Manager ISSUE: Praxair Inc. issued a recall of the Grab ‘n Go Vantage Portable Oxygen Cylinder unit because … Continue reading
Posted in FDA 2012, FDA Recall, Risk Manager
Tagged Class 1 Recall, Class I Recall, FDA recall, Grab n Go Vantage, Portable Oxygen Cylinder, Praxair Inc, Praxair Inc Grab n Go Vantage Portable Oxygen Cylinder Class I Recall, Recall
Comments Off
GE Healthcare T-Piece Circuits Class I Recall
GE Healthcare T-Piece Circuits for the Giraffe and Panda Resuscitation Systems: Class I Recall – Failure to Achieve the Desired Inspiratory Pressure During Ventilation AUDIENCE: Emergency Medicine, Pediatrics, Risk Manager ISSUE: The disposable T-piece circuits do not achieve the maximum … Continue reading
Posted in Emergency Rooms, FDA 2012, FDA Recall, Pediatrics, Risk Manager
Tagged Class I Recall, Emergency Medicine, GE Healthcare, GE Healthcare T-Piece Circuits Class I Recall, Pediatrics, Risk Manager, T-Piece Circuits
Comments Off
Zimmer Spine PEEK Ardis Inserter Class I Recall
Zimmer Spine – PEEK Ardis Inserter: Class I Recall – Risk of Implant Breakage AUDIENCE: Surgery, Risk Manager ISSUE: Zimmer Spine has received reports of the PEEK Ardis Interbody Spacer breaking into fragments when too much lateral force is applied … Continue reading
Posted in FDA 2012, FDA Recall, Risk Manager, Surgery
Tagged Class 1 Recall, Class I Recall, FDA recall, PEEK Ardis Inserter, Recall, Risk Manager, Surgery, Zimmer Spine, Zimmer Spine PEEK Ardis Inserter Class I Recall
Comments Off
Ventlab Adult and Pediatric Manual Resuscitators Recall
Ventlab Adult and Pediatric Manual Resuscitators: Recall-Valve Leak Prevents Flow of Air/Oxygen to Patient Audience: Risk Manager, Anesthesiology ISSUE: The affected manual resuscitators may have a valve leak which prevents the flow of air/oxygen to the patient. This lack of … Continue reading
Posted in Anesthesiology, FDA 2012, FDA Recall, Risk Manager
Tagged Anesthesiology, Pediatric Manual Resuscitators, Recall, Risk Manager, Ventlab Adult, Ventlab Adult and Pediatric Manual Resuscitators Recall
Comments Off
Bunnell Life Pulse High-Frequency Ventilator Patient Circuits Recall
Bunnell Life Pulse High-Frequency Ventilator Patient Circuits: Recall- Melted Insulation Can Cause Sparking and Smoke Audience: Risk Manager, Anesthesiology ISSUE: FDA notified healthcare professionals and their provider organizations that this product has been found to have heater wire insulation … Continue reading
Medtronic Drug Infusion Pumps Recall
Medtronic Drug Infusion Pumps: Recall – Intermittent or Permanent Pump Motor Stall SynchroMed II ImplantableSynchroMed EL Implantable Audience: Risk Manager, Physical Medicine, Neurosurgery ISSUE: FDA and Medtronic notified healthcare professionals that using unapproved drugs with the SynchroMed Infusion Pump … Continue reading
Posted in FDA 2012, FDA Recall, Neurology, Physical Medicine, Risk Manager
Tagged Drug Infusion Pumps, Medtronic, Medtronic Drug Infusion Pumps Recall, Neurosurgery, Physical Medicine, Recall, Risk Manager
Comments Off
Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg 500 mg Recall
Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall – Potential for Oversized Tablets Qualitest/Endo Health Mylan UPDATE 12/21/2012: Mylan announced a voluntary nationwide recall to the retail level of three lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 … Continue reading
Pradaxa dabigatran etexilate mesylate Drug Safety Communication
Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication – Should Not Be Used in Patients with Mechanical Prosthetic Heart Valves AUDIENCE: Cardiology, Patient ISSUE: The U.S. Food and Drug Administration (FDA) is informing health care professionals and the public that the … Continue reading
Posted in Cardiology, FDA 2012, FDA Notice, FDA Warning, Patients
Tagged dabigatran etexilate mesylate, Drug Safety Communication, Pradaxa, Pradaxa (dabigatran etexilate mesylate) Drug Safety Communication
Comments Off
Xyrem sodium oxybate Drug Safety Communication
Xyrem (sodium oxybate): Drug Safety Communication – Warning Against Use With Alcohol or Drugs Causing Respiratory Depression AUDIENCE: Neurology, Internal Medicine, Patient ISSUE: FDA reminded healthcare professionals and patients that the combined use of Xyrem (sodium oxybate) with alcohol or … Continue reading
Posted in FDA 2012, FDA Safety Communication, Internal Medicine, Neurology, Patients
Tagged Drug Safety Communication, Internal Medicine, Neurology, Patient, sodium oxybate, Xyrem, Xyrem sodium oxybate Drug Safety Communication
Comments Off